Heterobifunctional small molecules to modulate RNA function.

Area of Science:

• Biochemistry
• Molecular Biology
• Chemical Biology

Background:

• Ribonucleic acid (RNA) performs diverse cellular functions, including gene regulation and protein synthesis, through complex structural interactions.
• Small molecules targeting RNA structures have emerged, but simple binding often lacks sufficient biological activity.
• Heterobifunctional compounds represent a novel strategy to overcome limitations of simple RNA binders.

Purpose of the Study:

• To review recent progress in RNA-targeted heterobifunctional compounds.
• To showcase representative case studies of these compounds.
• To identify limitations and propose future development strategies for enhanced RNA-targeted molecules.

Main Methods:

• Literature review of recent advancements in RNA-targeted heterobifunctional compounds.
• Analysis of representative case studies demonstrating compound efficacy.
• Identification of critical gaps and limitations in the current field.

Main Results:

• Heterobifunctional compounds can covalently bind to RNA targets, alter RNA sequence, or induce RNA cleavage.
• These compounds demonstrate augmented functionalities compared to simple RNA binders.
• Representative case studies illustrate the potential of this therapeutic modality.

Conclusions:

• RNA-targeted heterobifunctional compounds show significant promise for modulating RNA function.
• Further development is needed to address current limitations and optimize molecular design.
• A strategic pathway for future advancements in RNA-targeted therapeutics is proposed.